D5BH:F:F-Xtrackers - MSCI Canada UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 83.05

Change

-0.87 (-1.04)%

Market Cap

N/A

Volume

130.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-15 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

-0.22 (-0.80%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

-0.42 (-0.82%)

USD 114.95B
SXR8:F iShares Core S&P 500 UCITS ETF..

-9.16 (-1.53%)

USD 98.13B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

N/A

USD 91.82B
XDNY:F Xtrackers MSCI Japan ESG Scree..

-0.10 (-0.63%)

USD 54.47B
VUSA:F Vanguard Funds Public Limited ..

-1.74 (-1.62%)

USD 51.63B
VUAA:F Vanguard S&P 500 UCITS Acc

-1.69 (-1.57%)

USD 51.63B
SXRZ:F iShares VII PLC - iShares Nikk..

-3.70 (-1.56%)

USD 50.58B
XJSE:F Xtrackers II - Japan Governmen..

+0.08 (+1.05%)

USD 40.89B
0ZC:F Zscaler Inc

-8.14 (-4.11%)

USD 37.92B

ETFs Containing D5BH:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 22.87% 82% B 74% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 22.87% 80% B- 71% C-
Trailing 12 Months  
Capital Gain 32.90% 85% B 75% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 32.90% 84% B 72% C
Trailing 5 Years  
Capital Gain 65.21% 82% B 76% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 65.21% 82% B 73% C
Average Annual (5 Year Horizon)  
Capital Gain 12.77% 81% B- 73% C
Dividend Return 12.77% 79% B- 66% D+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 16.99% 31% F 73% C
Risk Adjusted Return 75.18% 81% B- 85% B
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.